A Relative Bioavailability and Food Effect Study of New Formulations

NCT01398475 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Inflammatory Disorder
Arthritis, Rheumatoid

Interventions

DRUG: LY3009104

Sponsor

Eli Lilly and Company

Collaborators

[object Object]